Last reviewed · How we verify

Ciclopirox Olamine Topical Suspension

Padagis LLC · Phase 1 active Small molecule

Ciclopirox Olamine Topical Suspension is a topical antifungal agent used primarily for treating tinea pedis. It has completed a safety and equivalence trial and is under investigation for toenail onychomycosis. The drug is not FDA-approved but is marketed by Padagis LLC.

At a glance

Generic nameCiclopirox Olamine Topical Suspension
SponsorPadagis LLC
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: